SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-14-026563
Filing Date
2014-04-09
Accepted
2014-04-09 08:01:14
Documents
11
Period of Report
2014-04-09
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a14-10238_18k.htm 8-K 26658
2 EX-99.1 a14-10238_1ex99d1.htm EX-99.1 33018
3 GRAPHIC g102381mmi001.gif GRAPHIC 173887
4 GRAPHIC g102381mmi002.gif GRAPHIC 178554
5 GRAPHIC g102381mmi003.gif GRAPHIC 91680
6 GRAPHIC g102381mmi004.gif GRAPHIC 102787
7 GRAPHIC g102381mmi005.gif GRAPHIC 80368
8 GRAPHIC g102381mmi006.gif GRAPHIC 150640
9 GRAPHIC g102381mmi007.gif GRAPHIC 109582
10 GRAPHIC g102381mmi008.gif GRAPHIC 111762
11 GRAPHIC g102381mmi009.gif GRAPHIC 100125
  Complete submission text file 0001104659-14-026563.txt   1576899
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 14752479
SIC: 2834 Pharmaceutical Preparations